Plan to Mask Medical Experimentation on Minorities as “Racial Justice”

[Lauren Johnson]

Whitney Webb series Part 1

Under the guise of combatting “structural racism,” the Johns Hopkins Center for Health Security has laid out a strategy for ethnic minorities and the mentally challenged to be vaccinated first, all “as a matter of justice.” However, other claims made by the Center contradict these social justice talking points and point to other motives entirely.

With the first COVID-19 vaccine candidate set to receive an Emergency Use Authorization (EUA) from the US government in a matter of days, its distribution and allocation is set to begin “[color=var(--cs-color-primary)]within 24 hours” of that vaccine’s imminent approval.[/color]

The allocation strategy of COVID-19 vaccines within the US is set to dramatically differ from previous national vaccination programs. One key difference is that the vaccine effort itself, known as Operation Warp Speed, is [color=var(--cs-color-primary)]being almost completely managed by the US military, along with the Department of Homeland Security (DHS) and the National Security Agency (NSA), as opposed to civilian health agencies, which are significantly less involved than previous national vaccination efforts and have even been barred from attending some Warp Speed meetings. In addition, for the first time since 2001, law enforcement officers and DHS officials are set to not be prioritized for early vaccination.[/color]

Another key difference is the plan to utilize a phased approach that targets “populations of focus” identified in advance by different government organizations, including the CDC’s Advisory Committee on Immunization Practices (ACIP). Characteristics of those “populations of focus,” also referred to as “critical populations” in official documentation, will then be identified by the secretive, Palantir-developed software tool known as “Tiberius” to guide Operation Warp Speed’s vaccine distribution efforts. Tiberius will provide Palantir access to sensitive health and demographic data of Americans, which the company [color=var(--cs-color-primary)]will use to “help identify high-priority populations at highest risk of infection.”[/color]

This report is the first of a three-part series unmasking the racist components of the Pentagon-run project to both develop and distribute a COVID-19 vaccine. It explores the COVID-19 vaccine allocation strategy first outlined by the Johns Hopkins Center for Health Security and subsequent government allocation strategies that were informed by Johns Hopkins.

The main focus of this allocation strategy is to deliver vaccines first to racial minorities but in such a way as to make those minorities feel “at ease” and not like “guinea pigs” when receiving an experimental vaccine that those documents admit is likely cause “certain adverse effects…more frequently in certain population subgroups.” Research has shown that those “subgroups” most at risk for adverse effects are these same minorities.

The documents also acknowledge that information warfare and economic coercion will likely be necessary to combat “vaccine hesitancy” among these minority groups. It even frames this clearly disproportionate focus on racial minorities as related to national concerns over “police brutality,” claiming that giving minorities the experimental vaccine first is necessary to combat “structural racism” and ensure “fairness and justice” in the healthcare system and society at large.

Part 2 of this series will discuss how Palantir, a company currently helping DHS and law enforcement violently target African Americans and Latinos, will be in charge of allocating “tailored” COVID-19 vaccines to those same minorities as well as Palantir’s origins and its executives’ views on race. Part 3 will explore the direct ties between a COVID-19 vaccine front-runner and the Eugenics Society, which was re-named the Galton Institute in 1989.

The Planners

The Trump administration been criticized for its rush to develop and deploy a COVID-19 vaccine and particularly for installing Monclef Slaoui, a former pharmaceutical executive with ongoing conflicts of interest, as chief scientific adviser for Operation Warp Speed, the Pentagon-run program to produce and distribute the vaccine. Yet, if and when a Biden administration takes power, Operation Warp Speed is set to proceed with little, if any, modification.

The Johns Hopkins Center for Health Security (CHS) director Tom Inglesby, who will [color=var(--cs-color-primary)]serve on the Biden Health and Human Services (HHS) [color=var(--cs-color-primary)]transition team, has praised Slaoui, telling [color=var(--cs-color-primary)]Stat News[/color] that the longer someone like him can remain in charge of the nation’s COVID-19 vaccine effort, “the better it is for the country.”[/color][/color]

Inglesby, who led discussions at the CHS’s [color=var(--cs-color-primary)]Event 201 exercise in October 2019 and who was one of the primary authors of the controversial Johns Hopkins [color=var(--cs-color-primary)]Dark Winter exercise in 2001, is emblematic of the US government’s and the mainstream media’s general reliance on the Johns Hopkins Bloomberg School of Public Health (of which CHS is part) for pandemic-related matters. Slaoui [color=var(--cs-color-primary)]regularly[/color] [color=var(--cs-color-primary)]appears[/color] [color=var(--cs-color-primary)]on[/color] [color=var(--cs-color-primary)]network[/color] [color=var(--cs-color-primary)]TV[/color] as a COVID-19 oracle and has been [color=var(--cs-color-primary)]called[/color] “one of the nation’s go-to experts on the spread of the coronavirus.” Readers may note that the Johns Hopkins “coronavirus tracker” has been used by virtually [color=var(--cs-color-primary)]every[/color] [color=var(--cs-color-primary)]mainstream[/color] [color=var(--cs-color-primary)]news[/color] source since the beginning of COVID-19 reporting. This relationship is expected to continue, if not intensify, in a Biden administration.[/color][/color]

Both [color=var(--cs-color-primary)]Kathleen Hicks, the lead on Biden’s Department of Defense (DOD) transition team, and [color=var(--cs-color-primary)]Alexander Bick, on Biden’s National Security Council transition team, are scholars at Johns Hopkins Kissinger Center for Global Affairs, reflecting the university’s broader influence on a future Biden administration. Yet, the most significant way the Biden transition intersects with Johns Hopkins is through the CHS.[/color][/color]

Originally called the Center for Civilian Biodefense Strategies, the CHS is a think tank within Johns Hopkins that regularly gives recommendations to both the US government and the World Health Organization and, like the Bill and Melinda Gates Foundation, has [color=var(--cs-color-primary)]emerged as a [color=var(--cs-color-primary)]voice [color=var(--cs-color-primary)]of [/color][color=var(--cs-color-primary)]authority[/color] on all matters COVID-19 in the US. The center’s founding director was D. A. Henderson, best known for his role in the WHO-sponsored smallpox vaccination campaign. Henderson also held several government positions, including serving as associate director of the Office of Science and Technology Policy under George H. W. Bush. He was also the longtime dean of the Johns Hopkins School of Public Health.[/color][/color]

more later or go to the link